Himalaya Nutravedics India IPO

Listed +11.3%
BSE SME Book Building

22–24 Sep 2026

Listed 29 Sep 2026
Price band ₹100–₹106 Issue size ₹27 cr, all fresh
Listed at₹118+11.3% vs issue price
Subscribed 2.21×
Min to apply (retail) ₹2,54,400 2400 shares, 2 lots of 1200 at the cap

ShareFollow

Reality checkWe ran 1 checks. None found a gap between the headline and the numbers.

Our IPO analysis

The five questions

  1. 1
    How it makes moneyOur first read of the document missed this. We are reading it again.
  2. 2
    Is it growing, and is profit turning into cash?Sales grew 3.0x from 2024 to 2026 (₹14.4 cr → ₹43.1 cr).
  3. 3
    How much cushion does it have?Our first read of the document missed this. We are reading it again.
  4. 4
    What you pay, and who gets the moneyAll the money raised goes to the company. At ₹106 you pay about ₹5.78 for every ₹1 of last year's profit.
  5. 5
    Who controls it, and what is on record?Promoters own 87% before the IPO. The document discloses 1 legal matter.

Read from the RHP, the offer document filed just before bidding opens.

Every check we run on an offer document, and how often each one fires →

Latest update:

Listed at ₹118 vs ₹106 issue price (+11.3%) · Day-one close ₹123 · Subscribed 2.21× (QIB 1.0× · NII 3.9× · Retail 2.6×) · Price band ₹100–₹106 · Closed 24 Sep 2026 · Listed 29 Sep 2026 (Confirmed)

How it actually listed

₹118 on open, against a ₹106 issue price +11.3%

It ended its first day at ₹123 (+15.9% against the issue price), per the BSE's price archive.

We were not recording a grey-market premium before it listed.

Subscriptionvia aggregator
QIB 1.00×
NII (total) 3.93×
Retail 2.56×
Offer document (RHP) ↗not cross-checked

What Himalaya Nutravedics India does

Himalaya Nutravedics India Limited is engaged in the manufacturing, marketing and distribution of Ayurvedic formulations and nutraceutical products in India, along with undertaking third-party contract manufacturing for similar companies. The company offers a diversified product portfolio comprising classical (Shastric) Ayurvedic formulations, proprietary Ayurvedic products and nutraceutical supplements across multiple dosage forms such as capsules, tablets, liquid orals and medicated oils.

Sales growth, 2Y
73%/yr

Himalaya Nutravedics India financials

Rs crore  ·  Annual
202420252026
Sales 142143
Operating Profit ———
OPM % ———
Net Profit ———
Total Debt 325

Latest year first. Earlier years are to the left.

Himalaya Nutravedics India IPO offer structure

Total issue size: ₹27 cr, all of it a fresh issue.

There is no offer for sale: all the money goes to the company.

Size and split come from a public aggregator rather than the exchange, cross-checked against a second.

Himalaya Nutravedics India promoters and holding

Himalaya Nutravedics India risks and strengths

Risks the company lists
  • We derive a significant portion of our revenue from the sale of products in the Ayurvedic products segment. (p.480)
  • We are dependent on and derive a substantial portion of our revenue from certain key customers. (p.480)
  • We have historically derived, and may continue to derive, a significant portion of our supply from top 10 suppliers. (p.480)
2 more the company lists
  • Our profitability may be adversely affected upon the expiry of tax benefits available under Section 80-IAC. (p.480)
  • Products returned by Stockists upon expiry may adversely affect our revenues, margins and inventory management. (p.481)

Himalaya Nutravedics India market and competition

In our business of Ayurvedic and nutraceutical formulations, we compete with other marketing companies operating on a pan India scale, and regional companies, all involved in the promotion and sale of Ayurvedic and Nutraceutical formulations.

Himalaya Nutravedics India outlook, as the document states it

Initially the moderation in own-brand contribution percentage was primarily on account of the Company's decision to undertake job work manufacturing to establish operational capabilities, build manufacturing expertise, and achieve scale. Subsequently, leveraging the experience and infrastructure thus developed, the Company pivoted towards scaling its own-brand business, resulting in increase in own-brand revenue in FY2026. Revenue growth was further supported by expansion of the Company's distribution network and marketing initiatives across key markets including Kerala, Gujarat, Uttar Pradesh, and Andhra Pradesh.

Himalaya Nutravedics India IPO: common questions

What was the Himalaya Nutravedics India IPO listing price?

The Himalaya Nutravedics India IPO listed at ₹118, 11.3% above its issue price of ₹106. The listing price is the opening price set by the pre-open call auction on listing day, as reported by the exchange. Listing price vs GMP for every recent IPO →

When does the Himalaya Nutravedics India IPO open and close?

The Himalaya Nutravedics India IPO opened for bidding on 22 Sep 2026 and closed on 24 Sep 2026. Under the T+3 timetable the basis of allotment is fixed on the working day after the close, refunds and demat credits follow a day later, and the shares list on the third working day after the close. Open, allotment and listing dates for every IPO →

What is the Himalaya Nutravedics India IPO price band?

The Himalaya Nutravedics India IPO price band is ₹100–₹106 per share. You can bid at any price inside the band, and a retail investor can bid at cut-off, which accepts the final issue price, usually the top of the band. The minimum investment is always worked out at that upper end. How book building sets the price →

What is the lot size and minimum investment for the Himalaya Nutravedics India IPO?

One lot is 1200 shares, and a retail application on this issue must be at least 2 lots, 2400 shares. That is about ₹2,54,400 at the upper end of the band. Lot size and minimum investment, explained →

How much is the Himalaya Nutravedics India IPO subscribed?

The Himalaya Nutravedics India IPO closed on 24 Sep 2026 subscribed 2.21× in total, the final figure: investors bid for that many times the shares on offer. Each category (QIB, NII and retail) is counted separately, and when retail is oversubscribed its allotment is decided by a lottery for one lot each. What "subscribed 3x" means →

When does the Himalaya Nutravedics India IPO list?

The Himalaya Nutravedics India IPO listed on 29 Sep 2026 on BSE SME. On listing day the shares go through a pre-open call auction from 9 to 10 am that sets the opening price, and normal trading starts at 10 am. Allotted shares reach demat accounts the working day before. Every SME IPO in one place →

How do I check the Himalaya Nutravedics India IPO allotment status?

On the allotment status page published by KFin Technologies, this issue's registrar, and on the exchange's basis of allotment. Those are the primary sources. If the issue was oversubscribed, retail allotment was decided by lottery, so a valid application does not mean shares. We do not hold allotment data and cannot look yours up. Allotment status links for every recent IPO →

Himalaya Nutravedics India IPO allotment status

Listed 29 Sep 2026. Allotment is decided and published by the registrar, not by us. This issue's registrar is KFin Technologies.

Check your allotment on the registrar's own page ↗

We do not hold allotment data and cannot look yours up. If the issue was oversubscribed, retail allotment was decided by lottery, so a valid application does not mean shares. How allotment is actually decided →

Check it at the source: The offer document · KFin Technologies (registrar) · BSE public issues · SEBI offer documents

Cite or reuse this data

You're welcome to quote these figures in an article, newsletter or report. Please credit us with a link to this page:

Source: Himalaya Nutravedics India IPO data, IPO agent by Kredfit, updated 23 Nov 2026. https://ipoagent.kredfit.com/ipo/himalaya-nutravedics-india-limited-270449.html
Source: <a href="https://ipoagent.kredfit.com/ipo/himalaya-nutravedics-india-limited-270449.html">Himalaya Nutravedics India IPO data – IPO agent by Kredfit</a> (updated 23 Nov 2026)